Hydrolysis kinetics of the prodrug myristyl nicotinate

References

• Carlson L. 2004. Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad‐spectrum lipid drug. Int J Clin Pract. 58(7):706–713.
   PubMed Web of Science ®Google Scholar
• Carlson L. 2005. Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review. J Intern Med. 258(2):94–114.
   PubMed Web of Science ®Google Scholar
• Chan O, Schmid H, Stilgenbauer L, Howson W, Horwell DC, Stewart BH. 1998. Evaluation of a targeted prodrug strategy to enhance oral absorption of poorly water-soluble compounds. Pharm Res. 15(7):1012–1018.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran S, Al-Ghananeem A, Riggs R, Crooks P. 2006. Synthesis and stability of two indomethacin prodrugs. Bioorg Med Chem Lett. 16(7):1874–1879.
   PubMed Web of Science ®Google Scholar
• Chapman M. 2006. How does nicotinic acid modify the lipid profile? European Heart Journal Supplements. 8(suppl_F):F54–F59.
   Web of Science ®Google Scholar
• Chow SC, Liu JP. 1995. Assay development. In: Statistical design and analysis in pharmaceutical sciences. Boca Raton (FL): CRC Press; p. 25–70.
   Google Scholar
• Connors K, Amidon G, Stella V. 1986. Chemical stability of pharmaceuticals: a handbook for pharmacists. Hoboken (NJ): John Wiley & Sons.
   Google Scholar
• Gilmer J, Moriarty L, Lally M, Clancy J. 2002. Isosorbide-based aspirin prodrugs: II. Hydrolysis kinetics of isosorbide diaspirinate. Eur J Pharm Sci. 16(4–5):297–304.
   PubMed Web of Science ®Google Scholar
• Granero G, Amidon G. 2006. Stability of valacyclovir: implications for its oral bioavailability. Int J Pharm. 317(1):14–18.
   PubMedGoogle Scholar
• Guo R, Long Y, Lu Z, Deng M, He P, Li M, He Q. 2020. Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS. J Acta Pharmaceutica Sinica B. 10(10):1977–1988.
   PubMed Web of Science ®Google Scholar
• Iley J, Mendes E, Moreira R, Souza S. 1999. Cleavage of tertiary amidomethyl ester prodrugs of carboxylic acids by rat liver homogenates. Eur J Pharm Sci. 9(2):201–205.
   PubMed Web of Science ®Google Scholar
• Jacobson E, Kim L, Kim M, Williams JD, Coyle D, Coyle W, Grove G, Rizer R, Stratton M, Jacobson M. 2007. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp Dermatol. 16(6):490–499.
   PubMed Web of Science ®Google Scholar
• Jacobson E, Kim H, Kim M, Wondrak G, Jacobson M. 2008. Developing topical prodrugs for skin cancer prevention. In: Alberts D, Hess L, editors. Fundamentals of cancer prevention. Cham: Springer; p. 215–237.
   Google Scholar
• Julius U, Fischer S. 2013. Nicotinic acid as a lipid-modifying drug–a review. Atheroscler Suppl. 14(1):7–13.
   PubMed Web of Science ®Google Scholar
• Kadar EP, Wujcik CE, Wolford DP, Kavetskaia O, 2008. Reviewer Guidance, Validation of Chromatographic Methods Reviewer Guidance, Validation of Chromatographic Methods, 1994. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 863(1):1-8.
   Google Scholar
• Karnes HT, March C. 1993. Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis. Pharm Res. 10(10):1420–1426.
   Google Scholar
• Kim C. 2004. Advanced pharmaceutics: physicochemical principles. Boca Raton (FL): CRC Press.
   Google Scholar
• Lallemand F, Perottet P, Felt-Baeyens O, Kloeti W, Philippoz F, Marfurt J, Besseghir K, Gurny R. 2005. A water-soluble prodrug of cyclosporine A for ocular application: a stability study. Eur J Pharm Sci. 26(1):124–129.
   PubMed Web of Science ®Google Scholar
• Lee H, Cooperwood J, You Z, Ko D. 2002. Prodrug and antedrug: two diametrical approaches in designing safer drugs. Arch Pharm Res. 25(2):111–136.
   PubMed Web of Science ®Google Scholar
• Lindholm J. 2004. Development and validation of HPLC methods for analytical and preparative purposes. Uppsala: Acta Universitatis Upsaliensis.
   Google Scholar
• Meesters, R. and Voswinkel, S., 2018. Bioanalytical method development and validation: from the USFDA 2001 to the USFDA 2018 guidance for industry. J Appl Bioanal. 4(3):67–73.
   Google Scholar
• Mehvar R, Dann R, Hoganson D. 2000. Kinetics of hydrolysis of dextran–methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes. J Control Release. 68(1):53–61.
   PubMed Web of Science ®Google Scholar
• Ngawhirunpat T, Kawakami N, Hatanaka T, Kawakami J, Adachi I. 2003. Age dependency of esterase activity in rat and human keratinocytes. Biol Pharm Bull. 26(9):1311–1314.
   PubMed Web of Science ®Google Scholar
• Nikas IP, Paschou SA, Ryu HS. 2020. The role of nicotinamide in cancer chemoprevention and therapy. Biomolecules. 10(3):477.
   PubMed Web of Science ®Google Scholar
• Qandil AM, Rezigue MM, Tashtoush BM. 2011. Synthesis, characterization and in vitro hydrolysis of a gemfibrozil-nicotinic acid codrug for improvement of lipid profile. Eur J Pharm Sci. 43(3):99–108.
   PubMed Web of Science ®Google Scholar
• Rittirod T, Hatanaka T, Kagami N, Katayama K, Koizumi T. 1999. Simultaneous transport and metabolism of nicotinic acid derivatives in hairless mouse skin. Biol Pharm Bull. 22(3):305–309.
   PubMed Web of Science ®Google Scholar
• Salvi A, Carrupt P-A, Mayer JM, Testa B. 1997. Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid. Drug Metab Dispos. 25(4):395–398.
   PubMed Web of Science ®Google Scholar
• Siavashani A, Mohammadi J, Maniura-Weber K, Senturk B, Nourmohammadi J, Sadeghi B, Huber L, Rottmar M. 2019. Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid. Biomater Sci. 8(1):148–162.
   PubMed Web of Science ®Google Scholar
• Simões MF, Valente E, Gómez MJ, Anes E, Constantino L. 2009. Lipophilic pyrazinoic acid amide and ester prodrugs: stability, activation and activity against M. tuberculosis. Eur J Pharm Sci. 37(3–4):257–263.
   PubMed Web of Science ®Google Scholar
• Sinha V, Kumria R. 2001. Colonic drug delivery: prodrug approach. Pharm Res. 18(5):557–564.
   PubMed Web of Science ®Google Scholar
• Stankovičová M, Bezáková Ž, Beneš L. 1999. Kinetics of hydrolysis of acetyl, valeroyl and nicotinoyl acyl derivatives of stobadine. Life Sci. 65(18–19):2007–2010.
   PubMed Web of Science ®Google Scholar
• Tao R, Gao M, Liu F, Guo X, Fan A, Ding D, Kong D, Wang Z, Zhao Y. 2018. Alleviating the liver toxicity of chemotherapy via pH-responsive hepatoprotective prodrug micelles. ACS Appl Mater Interfaces. 10(26):21836–21846.
   PubMed Web of Science ®Google Scholar
• Tashtoush BM, Bennamani A, Al-Taani B. 2013. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Pharm Dev Technol. 18(4):834–843.
   PubMed Web of Science ®Google Scholar
• Tashtoush BM, Kim H, Jacobson EL, Jacobson MK. 2007. Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier. Drug Dev Ind Pharm. 33(11):1176–1182.
   PubMed Web of Science ®Google Scholar
• Tashtoush BM, Qandil AM, Jacobson EL, Jacobson MK. 2008. Analysis and stability study of octyl nicotinate in aqueous solutions and skin homogenate by LC. Chroma. 68(1–2):135–138.
   Web of Science ®Google Scholar
• Tashtoush BM, Qasem J, Williams J, DeWald T, Jacobson E, Jacobson M. 2007. Analysis and stability study of myristyl nicotinate in dermatological preparations by high-performance liquid chromatography. J Pharm Biomed Anal. 43(3):893–899.
   PubMed Web of Science ®Google Scholar
• Validation of Compendial Methods U.
   Google Scholar
• Van Herck S, Hassannia B, Louage B, Compostizo R, De Coen R, Berghe W, Berghe T, De Geest B. 2019. Water-soluble withaferin A polymer prodrugs via a drug-functionalized RAFT CTA approach. European Polymer Journal. 110:313–318.
   Web of Science ®Google Scholar
• Wang F, Finnin J, Tait C, Quirk S, Chekhtman I, Donohue AC, Ng S, D'souza A, Tait R, Prankerd R. 2016. Feb 1 The hydrolysis of diclofenac esters: synthetic prodrug building blocks for biodegradable drug–polymer conjugates. J Pharm Sci. 105(2):773–785.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen J, Li Y, Cui X, Zheng X, Roberts C, Lu M, Elias S, Chopp M. 2008. Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice. Neurobiol Dis. 32(2):273–280.
   PubMed Web of Science ®Google Scholar
• Zheng X, Polli JE. 2010. Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT. Int J Pharm. 396(1–2):111–118.
   PubMedGoogle Scholar